Drug recall · January 29, 2014
Propofol Injectible Emulsion recall
Why: Presence of Particulate Matter: Glass defect located on the interior neck of the vial identified glass surface abrasions and visible embedded particulate matter which could result in the potential for small glass flakes or embedded metal particulate to become dislodged into the solution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Propofol Injectible Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, packaged in 5 Units x 20 mL per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.
- Lots / codes
Lot #: 27-568-DJ*, Exp 03/15, Note * may be followed by 01
- Quantity
- 126,425 vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- December 12, 2013 · Voluntary: Firm initiated
- Classified
- January 23, 2014
- Reported
- January 29, 2014
- Ended
- October 16, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Propofol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.